Biomaacx Nutri Sciences India Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 02-07-2024
- Paid Up Capital ₹ 1.55 Cr
as on 02-07-2024
- Company Age 15 Year, 23 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 8.20 Cr
as on 02-07-2024
- Revenue 423.24%
(FY 2022)
- Profit 111.80%
(FY 2022)
- Ebitda -7.74%
(FY 2022)
- Net Worth 3.95%
(FY 2022)
- Total Assets 55.41%
(FY 2022)
About Biomaacx Nutri Sciences India
The Corporate was formerly known as Biomax Nutri Sciences India Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.55 Cr.
The company currently has active open charges totaling ₹8.20 Cr.
Gowthami Abbireddy and Venkateswara Nallamilli serve as directors at the Company.
- CIN/LLPIN
U15500AP2009PTC065559
- Company No.
065559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Ethakota, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biomaacx Nutri Sciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gowthami Abbireddy  | Additional Director | 01-Sep-2022 | Current |
| Venkateswara Nallamilli | Director | 19-Oct-2009 | Current |
Financial Performance and Corporate Structure Insights of Biomaacx Nutri Sciences India.
Biomaacx Nutri Sciences India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 423.24% increase. The company also saw a substantial improvement in profitability, with a 111.8% increase in profit. The company's net worth moved up by a moderate rise of 3.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomaacx Nutri Sciences India?
In 2022, Biomaacx Nutri Sciences India had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Dec 2022 | ₹4.00 Cr | Open |
Andhra Bank Creation Date: 24 Feb 2010 | ₹4.20 Cr | Open |
How Many Employees Work at Biomaacx Nutri Sciences India?
Unlock and access historical data on people associated with Biomaacx Nutri Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomaacx Nutri Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomaacx Nutri Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
